BioAtla (BCAB) Assets (2020 - 2026)
BioAtla's Assets came in at $9.51 million for Q2 2026, down 65.0% from $27.13 million a year earlier but up 11.0% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, BioAtla's Assets was $13.83 million, down 73.6% from FY2024.
- Assets has declined in each of the last four years, with a five-year compound annual growth rate of -43.7% (FY2020 to FY2025).
- Going back by year, Assets was $52.42 million in FY2024 (-56.2%), $119.66 million in FY2023 (-47.0%), $225.74 million in FY2022 (-11.3%) and $254.42 million in FY2021 (+3.9%).
- The five-year range for quarterly Assets is $8.57 million (Q1 2026) to $277.58 million (Q3 2021).
- Year-over-year, Assets has declined for 17 consecutive quarters, with an average decline of 65.4% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 3.9%), and the weakest in Q1 2026 (a decline of 77.6%).
- Business Quant data shows BCAB's Assets at $8.57 million (Q1 2026), $13.83 million (Q4 2025) and $15.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - | 9.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.51 Mn |
| Mar 31, 2026 | 8.57 Mn |
| Dec 31, 2025 | 13.83 Mn |
| Sep 30, 2025 | 15.91 Mn |
| Jun 30, 2025 | 27.13 Mn |
| Mar 31, 2025 | 38.29 Mn |
| Dec 31, 2024 | 52.42 Mn |
| Sep 30, 2024 | 62.24 Mn |
| Jun 30, 2024 | 68.64 Mn |
| Mar 31, 2024 | 89.20 Mn |
| Dec 31, 2023 | 119.66 Mn |
| Sep 30, 2023 | 151.36 Mn |
| Jun 30, 2023 | 179.64 Mn |
| Mar 31, 2023 | 204.55 Mn |
| Dec 31, 2022 | 225.74 Mn |
| Sep 30, 2022 | 189.11 Mn |
| Jun 30, 2022 | 213.50 Mn |
| Mar 31, 2022 | 230.65 Mn |
| Dec 31, 2021 | 254.42 Mn |
| Sep 30, 2021 | 277.58 Mn |
API Access
BioAtla Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();